Form 4: Kristina Burow Reports Changes in Beneficial Ownership of Neumora Therapeutics, Inc.

Kristina Burow, a director and 10% owner of Neumora Therapeutics, Inc., filed a Form 4 detailing changes in her beneficial ownership, including the acquisition of restricted stock units and stock options.

Summary

• Kristina Burow, a director and 10% owner of Neumora Therapeutics, Inc. (NMRA), filed a Form 4 with the SEC on June 14, 2024.
• The filing reports changes in her beneficial ownership of NMRA securities.
• On June 13, 2024, Burow acquired 20,100 restricted stock units (RSUs) and stock options for 28,571 shares.
• The RSUs and stock options vest on the earlier of June 13, 2025, or the next Annual Meeting following June 13, 2024.
• The filing also corrects an error in a previous Form 4 filed on December 12, 2023, which overstated the amount of securities beneficially owned by 1,809,641 shares.
• Burow's direct holdings include 47,717 shares of common stock after disposing of some shares.
• She also has indirect ownership through various ARCH Venture Funds, including ARCH Venture Fund VII, VIII Overage, X, X Overage, and XII.
• Burow disclaims beneficial ownership of shares held by ARCH Venture Funds except to the extent of her pecuniary interest therein.

Sentiment

Score: 6

Explanation: Neutral sentiment as the filing primarily reports routine transactions and a correction of a previous error. The acquisition of RSUs and stock options is a positive sign, but the disposal of some shares tempers the overall sentiment.

Positives

• The acquisition of RSUs and stock options indicates a continued investment and alignment of interests with Neumora Therapeutics.
• The correction of the previous filing ensures accurate reporting of beneficial ownership.

Negatives

• The disposal of some shares of common stock may be viewed negatively, although the quantity is not specified.

Risks

• The vesting of RSUs and stock options is contingent on time-based criteria, which may not align perfectly with company performance.
• Indirect ownership through venture funds introduces complexity in assessing the true extent of individual influence and control.

Future Outlook

The vesting of RSUs and stock options is contingent on the earlier of one year from June 13, 2024, or immediately prior to the next Annual Meeting following June 13, 2024.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for corporate insiders in the US, ensuring transparency in the market.
• The reporting of indirect ownership through venture funds is common for companies backed by venture capital firms.
• The vesting schedules for RSUs and stock options are typical for executive compensation packages.

Stakeholder Impact

• Shareholders are informed about changes in insider ownership, which can influence investor confidence.
• Employees may be indirectly affected by changes in executive compensation and ownership structure.

Key Dates